We're matching consumers with the best skincare products.
And ensuring data privacy through the blockchain.
The major concern of consumers using DNA-based tests is absolute privacy; how does one know what a company does with the data? In our model, companies must operate within our defined scope of the ecosystem to match skincare products to consumer epigenetic profiles. Companies never access actual data or identifiable info. Data is tokenized and recorded on the blockchain ledger to create data provenance, allowing consumers to verify that their data is used solely for their own benefit.
First, we're generating epigenetic profiles of everyone's skin.
We've developed a direct-to-consumer personal epigenomics test to measure DNA methylation levels of a proprietary panel of genes that are responsible for key skin functions (e.g., aging, elasticity, moisture retention, etc.).
Our at-home kit non-invasively collects DNA from skin (rather than saliva) which properly reflects skin quality changes after environmental interaction.
6 Billion Skin Status Patterns
Actionable Report Results
Skin Beauty Improvement
Next, companies will target data segments with personalized products.
We're building a web platform so that companies can leverage tokenized data points to target consumer segments with new or existing products.
Targeting is filtered by our scientific matching algorithm, based on ingredients from published product information that we've indexed and their epigenetic effects on skin quality indicators that we test for.
Let's transform the skincare industry together.
By combining our disruptive technologies and an innovative model, we change the way consumers make their buying decisions. By commoditizing dynamic and scientifically-grounded skin profiles, we've created a brand new marketing channel for the skincare industry.
We incentivize consumers and build in responsible data usage through tokenization.
Companies use ECARE utility tokens to target products to matched consumers. Consumers receive a portion of ECARE when targeted with personalized products.
ECARE is fixed at $0.10 each with an inflatable supply and act as loyalty points to be spent toward more skincare tests, thereby generating more data and targetable segments.
We eliminate perceived intrusiveness.
ECARE moves seamlessly with credit card transactions which are anonymously recorded on the blockchain, enabling trackable transparency and accountability without revealing actual identity. Consumers know that any data sold is exclusively and directly for their own benefit, solving the biggest barrier to personal genomics or epigenomics.
Our market entry strategy has substance.
Unlike tokenized businesses that rely solely on elusive partnerships, our proprietary skincare test is a tangible product that gives us substantial leverage to build up the skincare data ecosystem. No FDA clinical trials or regulatory approval are required for cosmetic related offerings.
This is our journey towards becoming a household name.
EpigenCare Inc. Established in New York, USA
Epigenetic-based Skincare Test Successfully Developed and Proven
ICO Token Generation Event
Launch Marketing Campaign for Product Pre-Orders
Limited Launch of Beta Skincare Test
Full Skincare Test Launch to Public; Launch EpigenCare Network Open Beta
Launch Consumer Mobile Application
Launch Official EpigenCare Network Platform
Retail Distribution Initiative; Deploy API (Application Programming Interface)
Dermatologist/Spa/Beauty Salon Partnership Initiative
Integrate Deep-Learning Artificial Intelligence Elements Based on Epigenetic Skin Data; Develop Complementary A-I-Based Mobile Imaging Application